CHARACTERISTIC | NEW ANTIPSYCHOTIC PRESCRIPTION | ||
---|---|---|---|
ESTIMATED OR | 95% CI | P VALUE | |
Patient age (per 5-y increase) | 1.03 | 0.96–1.12 | .409 |
Male sex | 1.31 | 1.01–1.70 | .043 |
Residence in rural area* | 1.08 | 0.76–1.54 | .669 |
Health care provider age (per 5-y increase)† | 0.99 | 0.91–1.06 | .708 |
Male health provider | 1.32 | 0.98–1.80 | .070 |
Analgesic prescription‡ | 1.11 | 0.79–1.57 | .541 |
β-blocker prescription‡ | 1.12 | 0.78–1.61 | .533 |
Calcium channel blocker prescription‡ | 0.85 | 0.57–1.29 | .444 |
Steroid prescription‡ | 1.90 | 1.04–3.47 | .053 |
Antidepressant prescription‡ | 1.11 | 0.80–1.54 | .540 |
Polypharmacy (not including antipsychotics)§ | 1.14 | 0.86–1.51 | .362 |
Anti-dementia medication prescription‖ | 1.32 | 0.96–1.82 | .091 |
Depression | 1.13 | 0.85–1.52 | .407 |
COPD | 1.13 | 0.81–1.57 | .478 |
Diabetes | 1.06 | 0.79–1.42 | .682 |
Epilepsy | 1.21 | 0.62–2.35 | .587 |
Hypertension | 0.94 | 0.72–1.22 | .242 |
Osteoarthritis | 0.93 | 0.71–1.21 | .577 |
Parkinson disease | 1.62 | 1.02–2.56 | .051 |
COPD—chronic obstructive pulmonary disease, OR—odds ratio.
↵* Owing to missing patient residency information, this analysis is based on a sample of 4040 patients.
↵† Owing to missing information on health care provider age, this analysis is based on a sample of 3920 patients.
↵‡ Prescription of the medication in 6 months before the dementia diagnosis.
↵§ Prescription of 5 or more medications within a 30-day period in 6 months before the dementia diagnosis.
↵‖ Prescription for the medication on the day of diagnosis.